Zurich Medical

Executive Summary

Zurich Medical is a privately-held innovator in cardiovascular devices, headquartered in Seattle, WA, and founded in 2016. The company develops cost-effective, easy-to-use devices grounded in proven science and supported by clinical and economic evidence. By applying an appropriate level of technology, Zurich aims to reduce healthcare costs globally. Although the company has not disclosed specific product details or regulatory milestones, its focus on affordable cardiovascular solutions positions it well in a market demanding value-based care. Zurich’s commitment to clinical and economic validation suggests a disciplined approach to product development, which may lead to differentiated offerings in the competitive medtech landscape.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for Next-Generation Cardiovascular Device60% success
• H1 2027Publication of Clinical Study Results Demonstrating Cost-Effectiveness50% success
• Q2 2027Strategic Partnership or Distribution Agreement for Global Market Access40% success